Skip to content
beroni logo newberoni logo new
  • About
    • About Beroni
    • Our History
    • Board of Directors
    • Management Team
    • Vision, Mission and Values
  • R&D
    • R&D
    • PENAO
      • PENAO Introduction
      • About
      • Board & Senior Management
      • Asset Protection
      • Research & Development​
      • Value Proposition
  • Core Businesses
    • Cell Therapies
    • Anti-Cancer Drugs
    • Infectious Diseases
    • Infectious Diseases – COVID-19
    • E-commerce
  • Products
    • By Beroni China
    • By Beroni USA
    • By Beroni Biotech
  • Investors
    • Announcements
    • Financial Information
    • Corporate Governance
    • Stock Information
    • Globenewswire Press Releases
    • Medtech Outlook
    • Research Report
    • COVID-19 Vaccines Overview
    • FAQs
  • News
  • Contact
  • English
    • 简体中文
Menu Close

Daily Archives: 2020-12-31

  1. Home>
  2. 2020>
  3. December>
  4. 31
Read more about the article Major Events of Beroni Group Limited in 2020

Major Events of Beroni Group Limited in 2020

  • Post author:tnt
  • Post published:2020-12-31
  • Post category:2020
  • Post comments:0 Comments

From January 29 to February 4, President of Beroni USA Mr. Linfeng Li came to Guang Zhou with “Virus Hunter” Professor Walter Ian Lipkin, helping prevent and control COVID-19 outbreak.…

Continue ReadingMajor Events of Beroni Group Limited in 2020

Search Article

Arrange by Year

  • 2017 (10)
  • 2018 (24)
  • 2019 (25)
  • 2020 (17)
  • 2021 (11)
  • 2022 (8)
  • 2023 (4)

What’s New

  • Beroni Group was Invited to Attend the 4th World-Class Enterprises R&D and Innovation Management Forum
  • Successful Conclusion to the Conference of FET
  • Beroni and Shenyang University Of Chemical Technology Successfully Signed the Practice Base Agreement
  • Beroni Group Advances Research and Development of its Enhanced COVID-19 Antigen Rapid Test Kit
  • Wish You Happy New Year!

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

  • About Beroni
  • Our History
  • Board of Directors
  • Management Team
  • Vision, Mission, and Values

Core Businesses

  • Cell Therapy
  • Anti-Cancer Drugs
  • Infectious Diseases
  • E-Commerce

Products

  • By Beroni China
  • By Beroni Japan
  • By Beroni USA

Copyrights© Beroni Group 2019 | All rights reserved |

website by chase e-Design

Close Menu